Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04418557 · ClinicalTrials.gov registry record
COVID-19 and Obstetric Transmission
A clinical trial, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 64
- Enrollment target
NCT04418557: Completed study, sponsored by University Hospitals Cleveland Medical Center.
NCT04418557 is a clinical trial that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04418557 has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
Study Summary
The aim of this study is to capture data, laboratory markers, and clinical outcomes of obstetric and neonatal outcomes in cases of COVID-19 during pregnancy and of pregnancies exposed to a COVID-19 vaccine in Cuyahoga County.
Primary Outcome
Viral presence in any of the collected specimens
Interventions
- DIAGNOSTIC_TEST RT-PCR and antibody testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2020-04-28 |
| Est. Completion | 2021-07-15 |
What the finished NCT04418557 record still lists
NCT04418557 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which RT-PCR and antibody testing is the first listed.
NCT04418557 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04418557 about?
NCT04418557 is a clinical study titled "COVID-19 and Obstetric Transmission". The aim of this study is to capture data, laboratory markers, and clinical outcomes of obstetric and neonatal outcomes in cases of COVID-19 during pregnancy and of pregnancies exposed to a COVID-19 vaccine in Cuyahoga County.
What is the current status of trial NCT04418557?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2020-04-28. Estimated completion is 2021-07-15.
What interventions are being tested in trial NCT04418557?
The interventions under investigation include: RT-PCR and antibody testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04418557?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI